...
首页> 外文期刊>Parasites Vectors >Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina
【24h】

Serological and molecular prevalence of selected canine vector borne pathogens in blood donor candidates, clinically healthy volunteers, and stray dogs in North Carolina

机译:在北卡罗来纳州的献血者候选人,临床健康志愿者和流浪狗中,所选犬病媒传播的病原体的血清学和分子流行病学

获取原文
           

摘要

Background Canine vector borne diseases (CVBDs) comprise illnesses caused by a spectrum of pathogens that are transmitted by arthropod vectors. Some dogs have persistent infections without apparent clinical, hematological or biochemical abnormalities, whereas other dogs develop acute illnesses, persistent subclinical infections, or chronic debilitating diseases. The primary objective of this study was to screen healthy dogs for serological and molecular evidence of regionally important CVBDs. Methods Clinically healthy dogs (n?=?118), comprising three different groups: Gp I blood donor candidates (n?=?47), Gp II healthy dog volunteers (n?=?50), and Gp III stray dogs (n?=?21) were included in the study. Serum and ethylenediamine tetraacetic acid (EDTA) anti-coagulated blood specimens collected from each dog were tested for CVBD pathogens. Results Of the 118 dogs tested, 97 (82%) dogs had been exposed to or were infected with one or more CVBD pathogens. By IFA testing, 9% of Gp I, 42% of Gp II and 19% of Gp III dogs were seroreactive to one or more CVBD pathogens. Using the SNAP 4DX? assay, Gp I dogs were seronegative for Anaplasma spp., Ehrlichia spp., and B. burgdorferi (Lyme disease) antibodies and D. immitis antigen. In Gp II, 8 dogs were Ehrlichia spp. seroreactive, 2 were infected with D. immitis and 1 was B. burgdorferi (Lyme disease) seroreactive. In Gp III, 6 dogs were infected with D. immitis and 4 were Ehrlichia spp. seroreactive. Using the BAPGM diagnostic platform, Bartonella DNA was PCR amplified and sequenced from 19% of Gp I, 20% of Gp II and 10% of Gp III dogs. Using PCR and DNA sequencing, 6% of Gps I and II and 19% of Gp III dogs were infected with other CVBD pathogens. Conclusion The development and validation of specific diagnostic testing modalities has facilitated more accurate detection of CVBDs. Once identified, exposure to vectors should be limited and flea and tick prevention enforced.
机译:背景技术犬媒介传播疾病(CVBD)包括由节肢动物媒介传播的多种病原体引起的疾病。一些狗患有持续性感染,而没有明显的临床,血液学或生化异常,而另一些狗则患有急性疾病,持续性亚临床感染或慢性衰弱性疾病。这项研究的主要目的是筛选健康犬的区域重要CVBD的血清学和分子证据。方法临床上健康的狗(n = 118),分为三组:Gp I献血者候选物(n = 47),Gp II健康狗志愿者(n = 50)和Gp III流浪狗(n)。 ?=?21)包括在研究中。测试从每只狗收集的血清和乙二胺四乙酸(EDTA)抗凝血液标本的CVBD病原体。结果在测试的118只狗中,有97只(82%)的狗已经接触或感染了一种或多种CVBD病原体。通过IFA测试,9%的Gp I,42%的Gp II和19%的Gp III狗对一种或多种CVBD病原体具有血清反应活性。使用SNAP 4DX?实验中,Gp I犬的血清分别为Anaplasma spp。,Ehrlichia spp。和B. burgdorferi(莱姆病)抗体和D. immitis抗原。在Gp II中,有8条狗是埃里希氏菌。具有血清反应活性,其中2例感染了D.炎性线虫,1例感染了伯氏疏螺旋体(莱姆病)。在Gp III中,有6只狗感染了D. immitis,有4只是埃里希氏菌。血清反应活跃。使用BAPGM诊断平台,对Bartonella DNA进行PCR扩增,并从19%的Gp I,20%的Gp II和10%的Gp III狗中进行测序。使用PCR和DNA测序,6%的Gps I和II狗和19%的Gp III狗被其他CVBD病原体感染。结论特定诊断测试方法的开发和验证有助于更准确地检测CVBD。一旦确定,应限制对媒介的接触并加强对跳蚤和壁虱的预防。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号